Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
1 other identifier
observational
136
1 country
1
Brief Summary
The purpose of the study is to improve the efficacy of pulsed dye laser treatment of port wine stain birthmarks. Involvement in the protocol will involve formal documentation of the level of treatment pain, duration of post-treatment purpura and incidence of side effects. In addition, measurements will be taken of blood substances that promote blood vessel formation/regrowth and non-invasive reflectance measurements and photographs will be taken before and after treatment. The objective of this study is to document the degree of port wine stain lightening, the incidence of side effects and the presence of angiogenic factors induced during treatment with the pulsed dye laser in association with cooling agent. This information ultimately lead to improved treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 1999
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1999
CompletedFirst Submitted
Initial submission to the registry
October 4, 2007
CompletedFirst Posted
Study publicly available on registry
October 8, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedOctober 20, 2022
October 1, 2022
9.2 years
October 4, 2007
October 19, 2022
Conditions
Keywords
Study Arms (1)
Port wine stain Birthmark
Port wine stain Birthmark
Interventions
Eligibility Criteria
primary care clinic
You may qualify if:
- Diagnosis of PWS birthmark or age and sex matched control of a subject with a PWS birthmark
- Apparent good health as documented by medical history and physical examination
- Ability to understand and carry out subject instructions
You may not qualify if:
- Pregnancy
- History of cutaneous photosensitivity
- History of photodermatoses, skin cancer or other cancer
- Any therapy to the proposed treatment sites within the previous two months
- Current participation in any other investigational drug evaluation
- Concurrent use of known photosensitizing drugs
- Inability to understand and carry out subject instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Lase Institute Medical Clinic Unversity of California Irvine
Irvine, California, 92612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristen Kelly, M.D
Beckman Laser Institue University of California Irvine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Kristen Kelly, M.D.,Professor Departments of Dermatology and Surgery
Study Record Dates
First Submitted
October 4, 2007
First Posted
October 8, 2007
Study Start
December 1, 1999
Primary Completion
February 1, 2009
Study Completion
February 1, 2009
Last Updated
October 20, 2022
Record last verified: 2022-10